HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Houn, F Articles by Stefanek, M E Search for Related Content PubMed PubMed Citation Articles by Houn, F Articles by Stefanek, M E

The practice of prophylactic mastectomy: a survey of Maryland surgeons.

F Houn, K J Helzlsouer, N B Friedman and M E Stefanek

Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Md, USA.

OBJECTIVES. Bilateral prophylactic mastectomy is a drastic breast cancer preventive option for which indications are not standardized and efficacy has not been proven. To estimate the magnitude of this controversial practice, surgeons were surveyed on their recommendations about and performance of prophylactic mastectomy. METHODS. A cross-sectional survey was sent to general surgeons (n = 522), plastic surgeons (n = 80), and gynecologists (n = 801) licensed to practice in Maryland in 1992. Proportions responding were 41.9%, 66.3%, and 54.9%, respectively. In addition, there were 30 respondents who identified "other" as their specialty. The respondents were asked about the role of bilateral prophylactic mastectomy and the number of times they had recommended and performed it in a year. RESULTS. Seven hundred forty-two surgeons responded (51.8%). More plastic surgeons (84.6%) than general surgeons (47.0%) and gynecologists (38.3%) agreed that bilateral prophylactic mastectomy has a role in the care of high-risk women. Eighty-one percent of plastic surgeons had recommended the procedure, compared with 38.8% of general surgeons and 17.7% of gynecologists. CONCLUSIONS. Indications and practice patterns reveal heterogeneity of medical opinion and practice of prophylactic mastectomy. This study raises the need for better evaluation of the efficacy and appropriateness of prophylactic mastectomy.

This article has been cited by other articles:

				F. Eisinger Prophylactic mastectomy: ethical issues Br. Med. Bull., April 4, 2007; (2007) ldm003v1. [Abstract] [Full Text] [PDF]

				M. Stefanek, L. Hartmann, and W. Nelson Risk-Reduction Mastectomy: Clinical Issues and Research Needs J Natl Cancer Inst, September 5, 2001; 93(17): 1297 - 1297. [Abstract] [Full Text] [PDF]

				I. Unic, L. C.G. Verhoef, P. F.M. Stalmeier, and W. A.J. Van Daal Prophylactic Mastectomy or Screening in Women Suspected to Have the BRCA1/2 Mutation: A Prospective Pilot Study of Women's Treatment Choices and Medical and Decision-analytic Recommendations Med Decis Making, July 1, 2000; 20(3): 251 - 262. [Abstract] [PDF]

				A. Eisen, T. R. Rebbeck, W. C. Wood, and B. L. Weber Prophylactic Surgery in Women With a Hereditary Predisposition to Breast and Ovarian Cancer J. Clin. Oncol., May 9, 2000; 18(9): 1980 - 1995. [Abstract] [Full Text] [PDF]

				I. Unic, P. F.M. Stalmeier, L. C.G. Verhoef, and W. A.J. Van Daal Assessment of the Time-tradeoff Val ues for Prophylactic Mastectomy of Women with a Suspected Genetic Predisposition to Breast Cancer Med Decis Making, August 1, 1998; 18(3): 268 - 277. [Abstract] [PDF]